MG
Montreal Gazette
›Crown seeks 42-month prison term for Quebec trucker who caused collision that killed nine-year-old girl›MAX Power Announces AGSM Results and Appointment of New Director›Grand Opening of Glacier Ridge Village Marks a New Era of Lifestyle-Focused Community Living in Calgary›TFI International to Hold Annual Meeting of Shareholders›Definium Therapeutics Announces New Employee Inducement Grants›Royal Gold to Release First Quarter 2026 Results on May 6, 2026›PrairieSky Announces First Quarter 2026 Results›Montreal suspends city councillor for failing to submit financial report›John Carswell Announces Holdings in Canso Credit Income Fund›Drivers see some relief at the pumps as Ottawa suspends fuel excise tax›Cowan: Hall of Famer Chris Pronger can relate to Juraj Slafkovsky’s Canadiens journey›Questor Announces the Departure of President and CEO›Westland Benefits acquires BC-based Synchronized Employee Benefits Corporation›CUPE Ontario’s HCWCC Members Hold Round Table on the State of Long-Term Care at Queen’s Park›THEON Publication of 2025 Annual Report & Corporate Updates›Coke Canada Bottling Grows Iconic ‘Red Fleet’ with Addition of Volvo Electric Trucks in BC and Quebec›CARFAX Canada Used Vehicle Market Insights›Montreal man had consumed alcohol and drugs before he was stabbed to death, court told›Opposition calls on Montreal to maintain partial short-term rental ban›ImmunityBio Inc. (NASDAQ: IBRX) Investigated for Potential Federal Securities Laws Violations – Lowey Dannenberg, P.C.
Last updated: May 3, 2026, 6:30 a.m.